• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

Meati Raises $50M Series B for Mycelium-Based Meat Alternatives

by Ashlen Wilder
July 6, 2021July 6, 2021Filed under:
  • Alternative Protein
  • Featured
  • Funding
  • News
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Colorado-based Meati produces whole cuts of meat alternative analogs from mycelium, and today the start-up announced that it has raised $50 million in its series B round (news from Forbes). The round was led by Acre Venture Partners and BOND, with participation from Prelude Ventures, Congruent Ventures, and Tao Capital. This brings the company’s total funding to $109.1 million.

Meati uses fermentation to produce its alternative protein products, a technique that the Good Food Institute calls the third pillar of alternative protein. The company has so far introduced two products, a whole cut alternative steak and chicken breast. The mycelium steak was piloted at a restaurant in Boulder, Colorado last year, and the chicken alternative was only offered to select consumers that applied to taste test it. Through the versatility of mycelium, it is likely that Meati will be able to create a wide variety of alternative protein analogs.

This most recent round of capital will be used to develop an 80,000 square foot production plant in preparation for the startup’s commercial launch. According to the Forbes article, Meati’s goal is to be able to produce enough of its alternative protein in its new facility that would be the equivalent of 4,500 cows in a single day.

The Good Food Institute reported that approximately $1 billion has been invested into companies using fermentation to develop alternative protein. That being said, Meati faces a few competitors in this space. AtLast had an impressive funding round earlier this year ($40M), and is currently developing new alternative protein analogs alongside its existing bacon product. Prime Roots uses fermentation and fungi to craft various protein alternatives, including bacon, chicken, lobster, and beef. Focusing on the B2B realm, Mushlabs also ferments mycelium to create alternative proteins products.

Meati has stated that the commercial launch of its first product will be sometime in 2022. According to an article published on Techcrunch, the first commercial product will likely be a mycelium-based jerky.


Related

Get the Spoon in your inbox

Just enter your email and we’ll take care of the rest:

Find us on some of these other platforms:

  • Apple Podcasts
  • Spotify
Tagged:
  • alternative protein
  • fermentation
  • Funding
  • Meati

Post navigation

Previous Post C3 Raises $80M to Expand Its Virtual Food Hall Concept
Next Post Yandex Delivery Robots Coming to College Campuses Courtesy of Grubhub

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Get The Spoon in Your Inbox

The Spoon Podcast Network!

Feed your mind! Subscribe to one of our podcasts!

How ReShape is Using AI to Accelerate Biotech Research
How Eva Goulbourne Turned Her ‘Party Trick’ Into a Career Building Sustainable Food Systems
Combustion Acquires Recipe App Crouton
Next-Gen Fridge Startup Tomorrow Shuts Down
From Starday to Shiru to Givaudan, AI Is Now Tablestakes Across the Food Value Chain

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.